Blog Posts

JTO and JTO CRR Achieve Strong Impact Factors in Oncology and Respiratory Medicine – IASLC

IASLC/LinkedIn

Jun 21, 2025, 14:31

JTO and JTO CRR Achieve Strong Impact Factors in Oncology and Respiratory Medicine – IASLC

International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:

“We’re proud to share the continued impact of the Journal of Thoracic Oncology (JTO) and JTO Clinical and Research Reports (JTO CRR)!

JTO’s Impact Factor is 20.8, ranking:

#3 of 108 in Respiratory Medicine

#13 of 326 in Oncology

JTO remains a top-tier, high-impact journal, leading the way in thoracic oncology through a strong multidisciplinary approach, rapid editorial process, and global collaboration.

Great news for JTO CRR, our open-access sister journal now has an Impact Factor of 3.5 (up from 3.0), placing it in the top half of oncology journals and top third in respiratory medicine!

We thank our authors, reviewers, editorial teams, and the IASLC community for their support.”

Read further.

More posts featuring IASLC.

cancer IASLC International Association for the Study of Lung Cancer Journal of Thoracic Oncology JTO JTO Clinical and Research Reports JTO CRR OncoDaily Oncology

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter